| Secondary |
| Angina Pectoris |
21.6% |
| Product Used For Unknown Indication |
18.6% |
| Hypertension |
15.5% |
| Cardiac Failure |
14.4% |
| Heart Failure |
7.2% |
| Ihd |
6.2% |
| Acute Myocardial Infarction |
4.1% |
| Diabetes Mellitus |
4.1% |
| Hypercholesterolaemia |
2.1% |
| Myocardial Ischaemia |
2.1% |
| Schizophrenia |
2.1% |
| Tachycardia |
2.1% |
|
| Weight Decreased |
25.8% |
| Renal Failure Acute |
9.7% |
| Cholecystitis Acute |
6.5% |
| Hyperkalaemia |
6.5% |
| Long Qt Syndrome |
6.5% |
| Visual Impairment |
6.5% |
| Blindness Unilateral |
3.2% |
| Cholecystitis Infective |
3.2% |
| Dyspnoea |
3.2% |
| Fatigue |
3.2% |
| Granulomatous Liver Disease |
3.2% |
| Hallucination |
3.2% |
| Lung Disorder |
3.2% |
| Quality Of Life Decreased |
3.2% |
| Renal Failure |
3.2% |
| Sinus Bradycardia |
3.2% |
| Sudden Death |
3.2% |
| Syncope |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.5% |
| Hypertension |
9.1% |
| Drug Use For Unknown Indication |
8.7% |
| Coronary Artery Disease |
7.4% |
| Angina Pectoris |
6.9% |
| Type 2 Diabetes Mellitus |
4.7% |
| Lung Neoplasm Malignant |
4.5% |
| Prophylaxis |
4.5% |
| Haemorrhoidal Haemorrhage |
3.7% |
| Pain |
3.4% |
| Diabetes Mellitus |
3.0% |
| Cardiovascular Disorder |
2.9% |
| Ischaemic Heart Disease Prophylaxis |
2.7% |
| Myocardial Ischaemia |
2.7% |
| Hypercholesterolaemia |
2.4% |
| Cardiac Disorder |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Cardiac Failure |
1.5% |
| Dyslipidaemia |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
|
| Tremor |
12.1% |
| Hyperkalaemia |
9.1% |
| Hypoglycaemia |
7.6% |
| Renal Failure Acute |
7.6% |
| Troponin Increased |
7.6% |
| Vomiting |
6.1% |
| Angina Pectoris |
4.5% |
| Blood Creatinine Increased |
4.5% |
| Thrombocytopenia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Urticaria |
4.5% |
| Acute Coronary Syndrome |
3.0% |
| Chest Pain |
3.0% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Concomitant Disease Progression |
3.0% |
| Convulsion |
3.0% |
| Cough |
3.0% |
| Dizziness |
3.0% |
| Haemostasis |
3.0% |
| Multi-organ Failure |
3.0% |
|
| Interacting |
| Cardiac Failure |
81.3% |
| Product Used For Unknown Indication |
18.8% |
|
| Bronchospasm |
28.6% |
| Drug Interaction |
28.6% |
| Renal Failure Acute |
14.3% |
| Thrombocytopenia |
14.3% |
| Vomiting |
14.3% |
|
